A close look at what happens when kava and kratom are combined in a single product - the dual mechanism, what the 2025 clinical trial found, what the 2026 CDC data says, and how to use the Piña Colada Relax Shot responsibly.

The Piña Colada Relax Shot is the only product in Jubi's lineup that combines two botanicals in a single ready-to-drink format - kava and kratom together rather than either one alone. That combination is what makes it distinctive within the lineup, and it's also what makes it the product that most warrants a careful, honest explanation before use.

This guide covers what each ingredient is doing, how the combination changes the experience relative to either alone, what the clinical research on kava-kratom combinations actually shows, what the 2026 safety data says, and who this product is and isn't right for.

What Each Ingredient Is Doing

Kava (Piper methysticum) works primarily through kavalactone interaction with the brain's GABA system - the same inhibitory neurotransmitter pathway targeted by alcohol, benzodiazepines, and sleep medications, but through a different mechanism and without the same dependency profile. Kavalactones also interact with dopamine and serotonin receptors, which is why kava tends to produce a mildly euphoric, socially open feeling alongside the relaxation - loosened muscles, a quieted mind, a warm calm that doesn't impair cognition at social doses. A 2023 neuroimaging study published in Nutrients documented kava's direct modulation of GABA in the dorsal anterior cingulate cortex - a brain region specifically associated with anxiety regulation - providing neurobiological evidence for the anxiolytic effects users have described for centuries.

Kratom in the context of a relaxation product operates through a different set of mechanisms than in the energy and focus products. At the doses used in relaxation-oriented formulations, kratom's serotonergic (5-HT1A agonism) and mild opioid receptor activity produce mood elevation, warmth, and a sociable ease rather than the adrenergic stimulation that white vein kratom produces at energy-range doses. A PMC-published peer-reviewed study characterizing the pharmacology of both substances laid out the receptor interactions clearly: kratom's alkaloids show mu-opioid agonism, alpha-2 adrenergic agonism, and 5-HT1A agonism - with the serotonergic and mood-modulating effects being the component most relevant to a relaxation-oriented product.

The combination is what makes the Piña Colada Relax Shot's effect profile distinct from the Strawberry Chill Kava Shot. Pure kava delivers GABA-mediated calm - often described as settling, quieting, slightly sedating at higher doses. Kava plus kratom adds a serotonergic warmth and mood-elevation layer on top of that calm - described by users as relaxation with sociability rather than relaxation trending toward sleep. Customer Billy M.'s description - "everything is at peace" - captures the kava foundation; the kratom component adds what other reviewers describe as warmth and ease, a quality of being both calm and present.

The Clinical Research: What the 2025 Trial Found

The most directly relevant clinical research for the kava-kratom combination format is a randomized, double-blind, placebo-controlled trial published in January 2025 in the peer-reviewed journal Cureus, which examined the short-term safety of a combined kava and kratom liquid blend over six days in healthy adults.

The findings are worth stating precisely: the combination was safe at standard doses, with no significant changes in liver enzymes or kidney function markers and no clinically meaningful withdrawal scores over the six-day period. Mild adverse effects - primarily nausea, headache, and fatigue - were reported, and these increased in frequency at the highest dose group tested. The study concluded the combination was generally tolerable for healthy adults in the short term at standard doses.

This is encouraging primary evidence for a specific combination that, prior to this trial, lacked controlled human research. The honest limits are equally important to state: six days is a short-term safety window, not a long-term safety profile. The trial does not address dependency risk over extended use, liver function over weeks or months, or use alongside other substances. It is a foundation, not a clearance.

The 2026 Safety Data: What the CDC Report Found

The April 2026 CDC MMWR report is the most significant new data point for anyone considering kava-kratom combination products, and it deserves honest coverage rather than a footnote.

A UVA Health study released alongside the MMWR analysis found that poison center calls involving kava rose 383% between 2011 and 2025, increasing from 57 to 203 reports. Critically, the CDC report specifically flagged rising poison-center reports linked to kratom-containing kava products - meaning the combination format is one of the contributors to this increase, not just single-ingredient kava use.

Dr. Christopher Holstege, director of UVA Health's Blue Ridge Poison Center, identified the central unanswered question directly: whether reported health effects are being caused by kava itself, by ingredients mixed into products, or by combinations of substances such as kava and kratom. That question is not yet answered by the available research - the Cureus trial provides six-day safety data; the CDC data reflects population-level adverse event patterns over fourteen years. Both pieces of evidence are real and deserve equal weight.

The pharmacological basis for caution is well-established: kava depresses the CNS through GABAergic pathways, while kratom does so via opioid receptor activation. Both mechanisms slow things down in the body, and when they operate simultaneously, the combined effect can be more intense than either substance alone. Research has noted that combining CNS depressants increases the risk of excessive sedation, drops in blood pressure, and in more serious scenarios, respiratory depression - the same pattern seen with alcohol-benzodiazepine combinations.

This is why the Piña Colada Relax Shot is not the right starting product for anyone new to kava or kratom - and why the safety guidelines below are not boilerplate, but specific and important.

Who This Product Is and Isn't For

Right for: experienced kava users who have established their individual kava response through the Strawberry Chill Kava Shot or Kava Stick Packs and want a product that adds mood elevation and warmth to the relaxation experience - for social evenings, occasions where mood matters alongside calm, or evenings where pure kava relaxation trends too sedating. Also suited to users already familiar with kratom in other Jubi products who understand their individual response.

Not right for: first-time users of either kava or kratom - the combination product is not the appropriate first experience with either ingredient. Anyone with liver concerns, or managing any health condition, should consult a healthcare provider before use. People on prescription medications - particularly antidepressants, benzodiazepines, opioids, or any CNS-active medication - should not use this product without explicit healthcare provider guidance, given the receptor overlap between the combination's mechanisms and several drug classes. Never combine with alcohol - the GABAergic and CNS-depressant overlap between alcohol and this product's mechanisms is the most important safety rule in the entire Jubi lineup.

The full comparison of kava products is in Energy, Focus, or Relaxation: Finding Your Perfect Match - and the case for starting with the Strawberry Chill before the Piña Colada Relax is covered there directly.

What to Actually Expect: First Use and Beyond

Onset: twenty to forty-five minutes is typical - the liquid format absorbs faster than capsules or traditional kava preparation, with the kratom component contributing a slightly faster onset relative to pure kava alone.

The experience: the Piña Colada Relax Shot's combination effect is most accurately described as layered - kava's GABA-mediated muscle relaxation and mental quieting as the foundation, kratom's serotonergic warmth and mood lift on top. Users describe feeling both calm and sociable rather than purely sedated - at ease without the sliding-toward-sleep quality that pure kava can produce at higher doses. The piña colada flavor profile - genuinely tropical, coconut-forward - is the most complex flavor in the kava lineup and the one most specifically designed around the ritual of a relaxing evening drink.

Duration: two to three hours is typical for the combined effect, with the kava component tending to linger longer than the kratom component as the evening progresses.

First use guidance: start at a half-serving on the first use, particularly if you haven't previously used a kava-kratom combination product. The combined CNS effect is more variable than either ingredient alone, and individual response to the combination differs from individual response to either ingredient in isolation. The Cureus trial's dose-dependent adverse effects at higher doses are a practical reason to start conservatively and assess before finishing the full serving.

Reverse tolerance: kava's well-documented reverse tolerance effect - where the experience becomes more pronounced with repeated exposure rather than less - applies to the kava component of this product. Second and third uses are often more clearly felt than the first.

The Piña Colada Flavor: Why It Works for This Product

This is the one area where the product's appeal is entirely non-pharmacological - and worth acknowledging directly because it's genuinely part of why this product works as an evening ritual rather than just a functional delivery mechanism.

The piña colada flavor profile has a specific cultural association with relaxation and tropical ease that no other flavor in the lineup has - it's not incidental that this is the combination product rather than the single-ingredient kava product. The coconut-pineapple flavor does something for the ritual context of an evening wind-down that "strawberry" or "cherry lime" doesn't - it places the experience in a specific sensory register that primes relaxation before the pharmacology has even had time to begin. More on why this pairing works at the flavor-psychology level is in Why Piña Colada Is the Flavor of Relaxation.

How It Fits Into a Full Evening Routine

For most users, the Piña Colada Relax Shot belongs in the same evening position as the Strawberry Chill or Kava Stick Packs - the wind-down after a demanding day, the transition from work mode to evening, the social occasion where an alcohol alternative is wanted. What it adds relative to those products is mood elevation and warmth alongside the relaxation floor.

For an experienced user whose evening routine already includes kava and is working well, the Piña Colada Relax is the natural step-up product for occasions that call for more dimension. For a new kava user, the Strawberry Chill is still the right starting point - establish your kava response individually before adding the kratom layer.

The full evening routine framework, including how kava products support the sleep quality that determines next-day energy and focus, is in Drinks That Fit Into a Calm Evening Routine and Jubi for Busy Professionals: A Smarter Beverage Choice.

Frequently Asked Questions

How is the Piña Colada Relax Shot different from the Strawberry Chill Kava Shot? The Strawberry Chill is pure kava - GABA-mediated relaxation and calm. The Piña Colada Relax combines kava with kratom, adding serotonergic mood elevation and warmth on top of the kava foundation. The result is relaxation with sociability rather than purely settling calm.

Is the kava-kratom combination safe? A January 2025 Cureus randomized controlled trial found the combination tolerable at standard doses in healthy adults over six days, with no significant liver or kidney function changes. The April 2026 CDC MMWR report flagged rising adverse-event reports linked to kava-kratom combination products broadly, underscoring the importance of responsible use, starting conservatively, and never combining with alcohol or other CNS-active substances.

Can I use this product if I'm on antidepressants? No - not without explicit guidance from your prescribing healthcare provider. Kratom's serotonergic activity creates interaction risk with antidepressants, including potential serotonin syndrome risk with SSRIs and SNRIs. This is a hard safety line, not a general precaution.

Should I start with this product or the Strawberry Chill? Always start with the Strawberry Chill if you're new to kava. Establish your individual kava response before adding the combination product.

What's the right first dose? Half a serving on the first use - assess your individual response to the combination before consuming the full serving. The Cureus trial's finding of dose-dependent adverse effects at higher doses is the practical reason to start low.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Not for sale to persons under the age of 18 or the legal age for kratom use in your state. Consult a healthcare provider before use if you are pregnant, nursing, have a serious medical condition, or take prescription medications. Do not combine kava or kratom with alcohol. Some products may be habit forming or lead to addiction. For the full warning statement, visit DrinkJubi.com.

Jubi does not ship to: Alabama, Arkansas, Indiana, Louisiana, Vermont, Wisconsin, Sarasota County (FL), Union County (MS), Suffolk County (NY), Denver (CO), San Diego (CA), Oceanside (CA), or Washington D.C. Please verify local regulations before purchasing.